EUVIMEDEUVIMED entdecken
Crossref

Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy.

Journal of Chemical Health Risks · 29.04.2026

DOI: 10.52783/jchr.v16.i2.13541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Health Risks, online erschienen am 29.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy. Journal of Chemical Health Risks. https://doi.org/10.52783/jchr.v16.i2.13541

Vancouver

Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy. Journal of Chemical Health Risks. 2026. doi:10.52783/jchr.v16.i2.13541

BibTeX
@article{euvimed2026,
  title = {Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy},
  journal = {Journal of Chemical Health Risks},
  year = {2026},
  doi = {10.52783/jchr.v16.i2.13541}
}
Kostenlos starten →